Novel Therapy Lands Speedy Approval for Wart-Like Airway Disease
(MedPage Today) -- The FDA granted accelerated approval to doruxapapogene ralaplasmid and lalikinogene sifuplasmid (Voceryq) to reduce the frequency of surgical papilloma excisions in adults with recurrent respiratory papillomatosis (RRP), the...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.